Medtronic (MDT) Cost of Revenue (2014 - 2026)

Medtronic has disclosed Cost of Revenue across 13 years of filings, most recently posting $3.3 billion for Q1 2026.

• Cost of Revenue for Q1 2026 came in at $3.3 billion, up 17.34% year-over-year; the trailing twelve-month figure through Jan 2026 was $12.5 billion (up 8.15% YoY), and the FY2025 annual result was $11.6 billion, up 3.71% from the prior year.
• Cost of Revenue came in at $3.3 billion for Q1 2026 at Medtronic, up from $3.1 billion in the prior quarter.
• In the past five years, Cost of Revenue ranged from a high of $3.3 billion in Q1 2026 to a low of $2.5 billion in Q1 2022.
• The 5-year median for Cost of Revenue is $2.8 billion (2025), against an average of $2.8 billion.
• Across the five-year window, Cost of Revenue dropped 6.18% in 2022 and climbed 17.34% in 2026, its largest moves.
• Medtronic's Cost of Revenue stood at $2.5 billion in 2022, then rose by 8.92% to $2.8 billion in 2023, then climbed by 6.7% to $2.9 billion in 2024, then gained by 3.9% to $3.1 billion in 2025, then increased by 6.53% to $3.3 billion in 2026.
• The last three Cost of Revenue figures came in at $3.3 billion (Q1 2026), $3.1 billion (Q4 2025), and $3.0 billion (Q3 2025), per Business Quant data.